Author Archive: Jessica Torres

Jessica Torres

Jessica is a Marketing & Web Content Manager in the marketing department at BIO. She keeps all the content for the business development conference event web pages up-to-date, optimizes email marketing campaigns to increase open and click-through rates, and leverages emerging social media tools to increase engagement among attendees at industry conferences and events. After a long day of marketing and social media strategy, she goes home and blogs about marketing and social media strategy on her personal website www.getstuckintraffic.com, and on Twitter.

Latest Posts

Be the Buzz of BIO at the 2016 BIO CEO and Investor Conference

Buzz of BIO contest, BIO Investor Forum

The nomination period is underway for the Buzz of BIO content at the 2016 CEO & Investor Conference! Each winner will receive a complimentary registration and presentation in the corresponding presentation track, and have the opportunity to impress investors with their company’s latest developments. The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

Stretching Your Dollar: Methods and Tools for Increasing the Productivity of Clinical Trials

admin-ajax.php

Recent Tufts data show clinical trials typically take nearly twice as long to complete enrollment as predicted at launch and 48% of trial sites miss enrollment targets.  Delays in trials shrink the returns from patent exclusivity and increase R&D costs.  New methods such as adaptive and batch trial designs, as well as explosive growth in digital tools, such as Apple’s ResearchKit, have transformed the trial design choices available.  These innovations, and others, provide new levers Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Investor Forum Session Recap: Precision Medicine: Leveraging National Genomic Databases for Therapy Development (U.S., UK, Iceland)

BIF-1

As the price point for full genome analysis falls through the $1,000 per person milestone, national efforts are ramping up for large studies that should enable much more personalized therapies.  This data should accelerate drug development by clarifying genetic targets and the most appropriate patient sub-groups for clinical trials. At the 14th Annual  BIO Investors Forum in San Francisco, a panel of precision medicine experts came together to share their perspectives on the current state Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Investor Forum Newly Added Sessions – Digital Health Spotlights

hyde pier

We are pleased to announce that two “digital health spotlight” sessions have been added to next week’s BIO Investor Forum program! If you haven’t yet registered, we encourage you to do so by clicking here an to check out the full program. Digital Health Spotlight #1—Investment Landscape and CEO Interview (Tuesday, October 20, 8:00-8:55am) Recent advances in mobile applications, miniaturization, and standards interoperability, plus the rising acceptance of patients willing to share healthcare interactions through digital channels, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

See What’s New at the 2015 BIO Investor Forum

hyde pier

The 2015 BIO Investor Forum is just two weeks away, and it’s gearing up to be the most productive Forum yet. The event will take place October 20-21, 2015 at the Parc 55 Hotel in San Francisco, California, and will feature several new programs and activities for attendees. Register now to join your colleagues for an exciting two days of networking, company presentations, BIO One-on-OneTM partnering meetings, and exciting expert-led panels. Here’s what to expect Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,